Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical ... ( Study Presented at American Society o...)

HOME >> MEDICINE >> NEWS

Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management

Date:4/27/2009

Study Presented at American Society of Breast Surgeons Conference Reveals New Diagnostic Technique Helps Guide Surgical Management

NEWPORT NEWS, Va., April 27 /PRNewswire/ -- A study from Beth Israel Medical Center, New York, revealed today that additional breast cancer was found in 9 percent of patients when Breast-Specific Gamma Imaging (BSGI) was used to complement mammography, substantially impacting surgical treatment. A total of 82 patients underwent BSGI for newly diagnosed breast cancer; of these, 18 had an additional abnormality, and 17 were biopsied. The findings were presented at the American Society of Breast Surgeons 2009 Annual Meeting in San Diego.

BSGI, a molecular breast imaging technique, is an adjunct to mammography that can see lesions independent of tissue density and discover early stage cancers. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "dark spots" on the BSGI image. The Dilon 6800 Gamma Camera is a high-resolution, compact gamma camera, optimized to perform BSGI.

"We wanted to determine the number of patients with known breast cancer who were found to have an additional lesion detected by BSGI, but undetected by mammography," said Dr. Susan K. Boolbol, Chief of Breast Surgery at Beth Israel Medical Center, New York. "In our study group, 22 percent of patients had a change in surgical management based on BSGI findings. This is critical information in our desire to diagnose breast cancer early for successful treatment."

BSGI provides the capability of helping differentiate cancer from other structures or benign tissue in the breast. Unlike mammography, BSGI is not affected by tissue density. The test is especially useful for pati
'/>"/>

2

GOOD

Page: 1 2
Related medicine news :

1. Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers Comp and Auto Providers and Payers
2. Siemens Further Develops its syngo Dynamics Solution
3. VirtualScopics Receives Further Extension to Regain Compliance With Nasdaq
4. LSTM and MiP Consortium awarded further $4.5 million
5. National Instruments to Further Medical Device Development With Grants in 2009
6. Regions Hospitals Engage in New Patient-Safety Efforts to Further Reduce Infections, Errors, and Improve Quality of Care
7. Nightmares increase risk of further suicide attempts
8. Further Acquisition for (London Based) Schofield Healthcare Media
9. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
10. To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International
11. Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety

Post Your Comments:

Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical ...( Study Presented at American Society o...),Health